IntuitiveUS46120E6023ISRGISRG
Financials
Market Cap
$141.46B5Y beta
1.36EPS (TTM)
$5.028Free Float
352.44MP/E ratio (TTM)
79.37Revenue (TTM)
$7.12BEBITDA (TTM)
$2.24BFree Cashflow (TTM)
$749.60MPricing
Analyst Ratings
The price target is $416.32 and the stock is covered by 28 analysts.
Buy
18
Hold
10
Sell
0
Information
Intuitive Surgical, Inc. develops, manufactures, and markets the da Vinci surgical system and the Ion endoluminal system. The Company's products and related services enable physicians and healthcare providers to access minimally invasive care. The da Vinci surgical system consists of a surgeon console or consoles, a patient-side cart, and a high-performance vision system. The da Vinci products fall into five categories, namely da Vinci surgical systems, da Vinci instruments and accessories, da Vinci Stapling, da Vinci Energy, and da Vinci Vision, including Firefly Fluorescence imaging systems and da Vinci Endoscopes. It also provides a comprehensive suite of systems, learning, and services offerings. The Ion endoluminal system consists of a system cart, a controller, a catheter, and a vision probe. It extends its commercial offerings beyond surgery into diagnostic procedures, enabling minimally invasive biopsies in the lung. Both systems use software, instruments, and accessories.